KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Cash from Investing Activities (2017 - 2025)

Historic Cash from Investing Activities for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to -$4.7 million.

  • Bionano Genomics' Cash from Investing Activities rose 1313.49% to -$4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.8 million, marking a year-over-year decrease of 18894.56%. This contributed to the annual value of $73.8 million for FY2024, which is 20565.03% up from last year.
  • According to the latest figures from Q3 2025, Bionano Genomics' Cash from Investing Activities is -$4.7 million, which was up 1313.49% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' Cash from Investing Activities registered a high of $47.6 million during Q1 2024, and its lowest value of -$185.6 million during Q3 2021.
  • In the last 5 years, Bionano Genomics' Cash from Investing Activities had a median value of $3.0 million in 2024 and averaged -$6.0 million.
  • In the last 5 years, Bionano Genomics' Cash from Investing Activities tumbled by 747559.18% in 2021 and then soared by 13328333.33% in 2022.
  • Bionano Genomics' Cash from Investing Activities (Quarter) stood at -$92.5 million in 2021, then surged by 112.55% to $11.6 million in 2022, then tumbled by 576.94% to -$55.4 million in 2023, then soared by 105.41% to $3.0 million in 2024, then tumbled by 255.79% to -$4.7 million in 2025.
  • Its last three reported values are -$4.7 million in Q3 2025, $2.0 million for Q2 2025, and -$14.1 million during Q1 2025.